Bringing the latest
cancer treatment
to Hong Kong
Share this article

Earlier this year, the future of cancer treatment arrived in the shape of the HK$40m TrueBeam system, made possible by a donation from LKSF

The Prince of Wales Hospital is the first public hospital in Hong Kong to offer the TrueBeam system, the most advanced linear accelerator and an innovative radiotherapy technology that represents a huge leap forward in terms of precision and fast delivery of radiation in cancer treatment.

TrueBeam allows for quicker treatment, meaning that patient discomfort will be reduced. The accuracy of the technology will also mean that risk is

Hong Kong, China
Mr Li Ka-shing has long been a supporter of The Chinese University of Hong Kong (CUHK), which partners with the Prince of Wales Hospital to provide vital training for student doctors. CUHK concentrates on finding ways to better serve citizens who are reliant on public medical services.

The HK$40 million gift to CUHK for the TrueBeam project is part of LKSF’s HK$300 million
“Love HK Your Way!” campaign

Professor Joseph J Y Sung, Vice Chancellor of CUHK, expressed his gratitude for the donation:

“On behalf of the University and all benefited patients, I would like to convey my heartfelt thanks to Mr Li for his care for the wellbeing of the general public and continuous support for education and medical development in Hong Kong. I would also like to thank the Hospital Authority and the Prince of Wales Hospital for their unfailing support in launching the service.”

The Chairman of the Hospital Authority, Mr Anthony Wu remarked:

“The system, which is the first being installed in public hospitals in Hong Kong, would benefit cancer patients by offering faster treatments, enhanced precision, and faster imaging at lower doses. It is also conducive to the advancement of clinical research and radiotherapy in Hong Kong.”


Mr Li said, “Advances in healthcare technology will no doubt shape the future of medical care. We are in a momentous time. Technologically and medically well-trained doctors, and innovative and evidence based data driven systems will empower and inform practitioners and patients alike, offering us the opportunity to enjoy good, precise care affordably.”

Besides the Prince of Wales Hospital, the School of Medicine of Stanford University and Shantou University Medical College’s Affiliated-Cancer Hospital have also received support from LKSF to acquire a TrueBeam system, in 2010 and June 2011 respectively.


A rare example of a cancer centre that has a dedicated palliative care team, the Prince of Wales Hospice is one of ten hospices in Hong Kong that we fund.

Our Heart of Gold Hospice Program was extended from Mainland China to Hong Kong in 2007. The program helps terminal cancer patients feel as comfortable and dignified as possible in their last leg of life.

“There is a need for a new type of care. Treatment has lengthened the survival period of patients.”

Dr Sing-fai Leung of Prince of Wales Hospice

The work that takes place at the Prince of Wales Hospice is typical of that which occurs across other Heart of Gold Hospices, but this is not to say that it is not remarkable. From support for cancer patients, to providing support to their families, palliative care is a highly important part of making suffering from cancer more bearable.

“Hospice care is all about extraordinary people taking the time to bring hope, and improve the lives of others,” said Li Ka-shing.

We pioneered the charitable hospice movement in China. Since 1998, over 150,000 terminally ill cancer patients have received treatment. To date, total funding for the “Heart of Gold” programs exceeds HK$510 million.

Dignity in death is priceless and care and respect for those with a terminal illness are key indicators of our social values and the mark of any civilised society

Li Ka-shing




Pro-Vice-Chancellor Chinese University of Hong Kong




Vice Chancellor

Chinese University

of Hong Kong



Associate Dean of Medicine Chinese University of Hong Kong